Capsule valuation, funding and investors
Capsule works in pharmacy services platform development, based in New York, United States. Founded in 2015, it has about 838 employees.
New York Growth Equity
VALUATION · TODAY
$999M −0% after Growth
Range $89.2M – $1.24B · Grade DTODAY
+12 MO
$1.00B
$2.00B
$3.00B
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series B $50.0M
Series C $200M
Growth $300M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY838 employees
+1%6m growth
+1%1y growth
+7%2y growth
500
1,000
Data from Jan 2021
Predicted in 1 yr $996M −0% vs today
Predicted next raise $107M if a round comes
Winding-down probability 2%
- Last round
- Growth · $300M · Apr 2021
- Valuation at last round
- $1.00B
- Headcount
- 838 · flat
- Grade
- D
- Founded
- 2015
Capsule valuation today
VCMC values Capsule at $999M today, with a range of $89.2M to $1.2B and a grade of D. The valuation starts from its last funding round, a growth round in Apr 2021.
Valuation by date (145 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2015 | $5.13M | $1.87M – $14.1M | $5.38M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $5.15M | $1.88M – $14.2M | $5.40M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $5.17M | $1.88M – $14.2M | $5.42M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $5.19M | $1.89M – $14.3M | $5.44M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $5.21M | $1.90M – $14.3M | $5.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $5.23M | $1.90M – $14.4M | $5.48M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $5.25M | $1.91M – $14.4M | $5.50M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $5.27M | $1.92M – $14.5M | $5.65M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $5.29M | $1.93M – $14.5M | $5.80M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $5.31M | $1.93M – $14.6M | $5.95M (+12%) | before first round | – | unknown | D | 0% |
| 1 Nov 2015 | $5.33M | $1.94M – $14.7M | $6.11M (+15%) | before first round | – | unknown | D | 0% |
| 1 Dec 2015 | $5.36M | $1.95M – $14.7M | $6.27M (+17%) | before first round | – | unknown | D | 0% |
| 1 Jan 2016 | $5.38M | $1.96M – $14.8M | $6.45M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $5.40M | $1.97M – $14.8M | $6.62M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $5.42M | $1.97M – $14.9M | $6.79M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $5.44M | $1.98M – $14.9M | $6.97M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $5.46M | $1.99M – $15.0M | $7.16M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $5.48M | $2.00M – $15.1M | $7.35M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $5.50M | $2.00M – $15.1M | $7.54M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $5.65M | $2.06M – $15.5M | $7.75M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $5.80M | $2.11M – $15.9M | $7.96M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $5.96M | $2.17M – $16.4M | $8.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $6.12M | $2.23M – $16.8M | $8.39M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $6.28M | $2.29M – $17.2M | $8.61M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $6.45M | $2.35M – $17.7M | $8.84M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $6.62M | $2.41M – $18.2M | $9.08M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $6.78M | $2.47M – $18.6M | $9.30M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $6.97M | $2.54M – $19.1M | $9.55M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $7.15M | $2.60M – $19.6M | $9.80M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $7.34M | $2.67M – $20.2M | $10.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $7.54M | $2.74M – $20.7M | $10.3M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $7.74M | $2.82M – $21.3M | $10.6M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $7.95M | $2.89M – $21.8M | $10.9M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $8.16M | $2.97M – $22.4M | $11.2M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $8.38M | $3.05M – $23.0M | $11.5M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $8.60M | $3.13M – $23.6M | $11.8M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $8.84M | $3.22M – $24.3M | $12.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $9.08M | $3.30M – $24.9M | $12.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $9.30M | $3.39M – $25.5M | $12.7M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $9.55M | $3.48M – $26.2M | $13.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2018 | $9.80M | $3.57M – $26.9M | $13.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2018 | $10.1M | $3.67M – $27.7M | $13.8M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2018 | $10.3M | $3.76M – $28.4M | $14.2M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2018 | $10.6M | $3.86M – $29.2M | $14.3M (+35%) | before first round | – | unknown | D | 0% |
| 15 Aug 2018 | $358M | $235M – $815M | $536M (+50%) | after a round | – | unknown | C | 0% |
| 1 Sep 2018 | $364M | $235M – $815M | $536M (+47%) | after a round | – | unknown | C | 0% |
| 1 Oct 2018 | $377M | $235M – $815M | $536M (+42%) | after a round | – | unknown | C | 0% |
| 1 Nov 2018 | $390M | $235M – $815M | $536M (+37%) | after a round | – | unknown | C | 0% |
| 1 Dec 2018 | $403M | $235M – $815M | $536M (+33%) | after a round | – | unknown | C | 0% |
| 1 Jan 2019 | $417M | $235M – $815M | $536M (+28%) | after a round | – | unknown | C | 0% |
| 1 Feb 2019 | $432M | $235M – $815M | $536M (+24%) | after a round | – | unknown | C | 0% |
| 1 Mar 2019 | $445M | $235M – $815M | $536M (+20%) | after a round | – | unknown | C | 0% |
| 1 Apr 2019 | $461M | $235M – $815M | $536M (+16%) | after a round | – | unknown | C | 0% |
| 1 May 2019 | $477M | $235M – $815M | $536M (+12%) | after a round | – | unknown | C | 0% |
| 1 Jun 2019 | $493M | $235M – $815M | $536M (+9%) | after a round | – | unknown | C | 0% |
| 1 Jul 2019 | $510M | $235M – $815M | $536M (+5%) | after a round | – | unknown | C | 0% |
| 1 Aug 2019 | $528M | $235M – $815M | $536M (+1%) | after a round | – | unknown | C | 0% |
| 1 Sep 2019 | $536M | $229M – $815M | $536M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2019 | $1.2B | $875M – $2.3B | $1.6B (+30%) | after a round | – | unknown | B | 0% |
| 1 Nov 2019 | $1.3B | $875M – $2.3B | $1.6B (+27%) | after a round | – | unknown | B | 0% |
| 1 Dec 2019 | $1.3B | $875M – $2.3B | $1.6B (+24%) | after a round | – | unknown | B | 0% |
| 1 Jan 2020 | $1.3B | $875M – $2.3B | $1.6B (+22%) | after a round | – | unknown | B | 0% |
| 1 Feb 2020 | $1.4B | $875M – $2.3B | $1.6B (+19%) | after a round | – | unknown | B | 0% |
| 1 Mar 2020 | $1.4B | $875M – $2.3B | $1.6B (+16%) | after a round | – | unknown | B | 0% |
| 1 Apr 2020 | $1.4B | $875M – $2.3B | $1.6B (+14%) | after a round | – | unknown | B | 0% |
| 1 May 2020 | $1.4B | $875M – $2.3B | $1.6B (+11%) | after a round | – | unknown | B | 0% |
| 1 Jun 2020 | $1.5B | $875M – $2.3B | $1.6B (+9%) | after a round | – | unknown | B | 0% |
| 1 Jul 2020 | $1.5B | $875M – $2.3B | $1.6B (+7%) | after a round | – | unknown | B | 0% |
| 1 Aug 2020 | $1.5B | $875M – $2.3B | $1.6B (+4%) | after a round | – | unknown | B | 0% |
| 1 Sep 2020 | $1.6B | $875M – $2.3B | $1.6B (+2%) | after a round | – | unknown | B | 0% |
| 1 Oct 2020 | $1.6B | $873M – $2.3B | $1.6B (0%) | after a round | – | unknown | B | 0% |
| 1 Nov 2020 | $1.6B | $833M – $2.3B | $1.6B (0%) | after a round | – | unknown | B | 0% |
| 1 Dec 2020 | $1.6B | $797M – $2.3B | $1.6B (0%) | after a round | – | unknown | B | 0% |
| 1 Jan 2021 | $1.6B | $761M – $2.3B | $1.6B (0%) | after a round | 450 | unknown | B | 0% |
| 1 Feb 2021 | $1.6B | $726M – $2.3B | $1.6B (0%) | after a round | 450 | unknown | B | 0% |
| 1 Mar 2021 | $1.6B | $696M – $2.3B | $1.6B (0%) | after a round | 450 | unknown | B | 0% |
| 1 Apr 2021 | $1.6B | $665M – $2.3B | $1.6B (0%) | after a round | 450 | flat | C | 0% |
| 30 Apr 2021 | $1.0B | $869M – $1.3B | $1.1B (+10%) | after a round | 450 | flat | A | 0% |
| 1 May 2021 | $1.0B | $869M – $1.3B | $1.1B (+10%) | after a round | 600 | up | A | 0% |
| 1 Jun 2021 | $1.0B | $869M – $1.3B | $1.1B (+9%) | after a round | 600 | up | A | 0% |
| 1 Jul 2021 | $1.0B | $869M – $1.3B | $1.1B (+8%) | after a round | 600 | up | A | 0% |
| 1 Aug 2021 | $1.0B | $869M – $1.3B | $1.1B (+7%) | after a round | 600 | up | A | 0% |
| 1 Sep 2021 | $1.0B | $869M – $1.3B | $1.1B (+6%) | after a round | 600 | up | A | 0% |
| 1 Oct 2021 | $1.0B | $869M – $1.3B | $1.1B (+6%) | after a round | 600 | up | A | 0% |
| 1 Nov 2021 | $1.0B | $869M – $1.3B | $1.1B (+5%) | after a round | 600 | up | A | 0% |
| 1 Dec 2021 | $1.1B | $869M – $1.3B | $1.1B (+4%) | after a round | 600 | up | A | 0% |
| 1 Jan 2022 | $1.1B | $869M – $1.3B | $1.1B (+3%) | after a round | 600 | up | A | 0% |
| 1 Feb 2022 | $1.1B | $869M – $1.3B | $1.1B (+2%) | after a round | 600 | up | A | 0% |
| 1 Mar 2022 | $1.1B | $869M – $1.3B | $1.1B (+2%) | after a round | 600 | up | A | 0% |
| 1 Apr 2022 | $1.1B | $869M – $1.3B | $1.1B (+1%) | after a round | 600 | up | A | 0% |
| 1 May 2022 | $1.1B | $868M – $1.3B | $1.1B (0%) | after a round | 600 | up | A | 0% |
| 1 Jun 2022 | $1.1B | $844M – $1.3B | $1.1B (0%) | after a round | 600 | up | A | 0% |
| 1 Jul 2022 | $1.1B | $822M – $1.3B | $1.1B (0%) | after a round | 600 | up | A | 0% |
| 1 Aug 2022 | $1.1B | $799M – $1.3B | $1.1B (0%) | after a round | 600 | up | A | 0% |
| 1 Sep 2022 | $1.1B | $777M – $1.3B | $1.1B (0%) | after a round | 600 | up | A | 0% |
| 1 Oct 2022 | $1.1B | $757M – $1.3B | $1.1B (0%) | after a round | 600 | up | A | 0% |
| 1 Nov 2022 | $1.1B | $641M – $1.3B | $1.1B (0%) | after a round | 600 | unknown | B | 0% |
| 1 Dec 2022 | $1.1B | $610M – $1.3B | $1.1B (0%) | after a round | 600 | unknown | B | 0% |
| 1 Jan 2023 | $1.2B | $614M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 Feb 2023 | $1.2B | $587M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 Mar 2023 | $1.2B | $565M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 Apr 2023 | $1.2B | $540M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 May 2023 | $1.2B | $518M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 Jun 2023 | $1.2B | $492M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 Jul 2023 | $1.2B | $468M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 Aug 2023 | $1.2B | $445M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 Sep 2023 | $1.2B | $423M – $1.4B | $1.2B (0%) | after a round | 880 | unknown | B | 0% |
| 1 Oct 2023 | $857M | $394M – $1.3B | $655M (-24%) | after a round | 800 | flat | C | 48% |
| 1 Nov 2023 | $844M | $375M – $1.3B | $640M (-24%) | after a round | 800 | flat | C | 48% |
| 1 Dec 2023 | $831M | $357M – $1.3B | $626M (-25%) | after a round | 800 | flat | C | 48% |
| 1 Jan 2024 | $818M | $339M – $1.3B | $612M (-25%) | after a round | 800 | flat | C | 48% |
| 1 Feb 2024 | $716M | $320M – $1.3B | $499M (-30%) | after a round | 780 | down | C | 62% |
| 1 Mar 2024 | $700M | $306M – $1.3B | $483M (-31%) | after a round | 780 | down | C | 62% |
| 1 Apr 2024 | $686M | $290M – $1.3B | $470M (-31%) | after a round | 780 | down | C | 62% |
| 1 May 2024 | $632M | $276M – $1.2B | $476M (-25%) | after a round | 780 | down | C | 62% |
| 1 Jun 2024 | $615M | $263M – $1.2B | $465M (-24%) | after a round | 780 | down | C | 62% |
| 1 Jul 2024 | $599M | $250M – $1.2B | $455M (-24%) | after a round | 780 | down | C | 62% |
| 1 Aug 2024 | $614M | $238M – $1.2B | $477M (-22%) | after a round | 780 | flat | C | 57% |
| 1 Sep 2024 | $630M | $226M – $1.2B | $498M (-21%) | after a round | 780 | flat | C | 53% |
| 1 Oct 2024 | $645M | $215M – $1.2B | $520M (-19%) | after a round | 780 | flat | C | 48% |
| 1 Nov 2024 | $661M | $205M – $1.2B | $543M (-18%) | after a round | 790 | flat | C | 45% |
| 1 Dec 2024 | $676M | $195M – $1.2B | $565M (-16%) | after a round | 790 | flat | C | 41% |
| 1 Jan 2025 | $689M | $185M – $1.2B | $586M (-15%) | after a round | 790 | flat | C | 38% |
| 1 Feb 2025 | $701M | $176M – $1.2B | $606M (-14%) | after a round | 790 | flat | C | 35% |
| 1 Mar 2025 | $714M | $168M – $1.2B | $627M (-12%) | after a round | 790 | flat | C | 32% |
| 1 Apr 2025 | $725M | $160M – $1.2B | $654M (-10%) | after a round | 790 | flat | C | 29% |
| 1 May 2025 | $750M | $152M – $1.2B | $680M (-9%) | after a round | 790 | flat | D | 27% |
| 1 Jun 2025 | $765M | $145M – $1.2B | $705M (-8%) | after a round | 790 | flat | D | 25% |
| 1 Jul 2025 | $782M | $138M – $1.2B | $732M (-6%) | after a round | 808 | flat | D | 23% |
| 1 Aug 2025 | $799M | $132M – $1.2B | $758M (-5%) | after a round | 823 | flat | D | 21% |
| 1 Sep 2025 | $812M | $125M – $1.2B | $779M (-4%) | after a round | 823 | flat | D | 19% |
| 1 Oct 2025 | $826M | $120M – $1.2B | $800M (-3%) | after a round | 826 | flat | D | 18% |
| 1 Nov 2025 | $838M | $114M – $1.2B | $819M (-2%) | after a round | 826 | flat | D | 16% |
| 1 Dec 2025 | $851M | $108M – $1.2B | $837M (-2%) | after a round | 828 | flat | D | 15% |
| 1 Jan 2026 | $862M | $103M – $1.2B | $854M (-1%) | after a round | 828 | flat | D | 14% |
| 1 Feb 2026 | $873M | $97.7M – $1.2B | $870M (0%) | after a round | 828 | flat | D | 13% |
| 1 Mar 2026 | $884M | $93.3M – $1.2B | $884M (0%) | after a round | 828 | flat | D | 12% |
| 1 Apr 2026 | $898M | $93.3M – $1.2B | $898M (0%) | after a round | 828 | flat | D | 11% |
| 1 May 2026 | $917M | $93.9M – $1.2B | $896M (-2%) | after a round | 851 | flat | D | 10% |
| 1 Jun 2026 | $929M | $93.9M – $1.2B | $909M (-2%) | after a round | 851 | flat | D | 9% |
| 1 Jul 2026 | $941M | $94.0M – $1.2B | $922M (-2%) | after a round | 854 | flat | D | 8% |
| 1 Aug 2026 | $1.0B | $94.0M – $1.2B | $1.0B (0%) | after a round | 854 | flat | D | 2% |
| 1 Sep 2026 | $1.1B | $94.0M – $1.2B | $1.0B (0%) | after a round | 854 | flat | D | 2% |
| 1 Oct 2026 | $1.0B | $93.6M – $1.2B | $1.0B (0%) | after a round | 838 | flat | D | 2% |
| 24 Oct 2026 | $999M | $89.2M – $1.2B | $996M (0%) | after a round | 838 | flat | D | 2% |
Key facts about Capsule
- Founded
- 2015
- Headquarters
- New York, United States
- Employees
- about 838 +1% in a year
- Total raised
- $550M
- Funding rounds
- 3
- Last round
- Growth Equity Apr 2021
Capsule was founded in 2015 by Eric Kinariwala.
Capsule funding history
Capsule has 3 funding rounds on record, from Aug 2018 to Apr 2021, $550M in total. The latest disclosed valuation is $1.00B post-money (Growth Equity, Apr 2021).
Growth Equity 29 Apr 2021
Led by Durable Capital Partners; with Baillie Gifford, T. Rowe Price.
Sources: telecareaware.com, fiercehealthcare.com
$300M
$1.00B post-money
Series C 30 Sep 2019
Led by Technology Crossover Ventures; with Thrive Capital, Glade Brook.
Sources: mobihealthnews.com, mobihealthnews.com, pulse2.com
$200M
$50M
Capsule investors
6 investors have backed Capsule; Glade Brook, Thrive Capital and Durable Capital Partners and 1 more led at least one round.
- Glade Brook lead, 2 rounds
- Thrive Capital lead, 2 rounds
- Durable Capital Partners lead
- Technology Crossover Ventures lead
- Baillie Gifford
- T. Rowe Price
What Capsule does
Capsule works in drug stores & pharmacies, with 10 recorded offerings and customers in healthcare.
Capsule Corporation is an American pharmacy service provider that operates a mobile application-based platform for same-day prescription delivery and medication management. The company coordinates with insurance providers to facilitate prescription fulfillment and offers patient support through direct communication with pharmacists. Capsule serves individual patients and healthcare organizations, including doctors, hospitals, insurers, and manufacturers, primarily in the United States.
Description from Veridion's company data.
Products and services
- Pharmacy Services Platform Development
- Prescription Delivery Services
- Medication Management Services
- Mobile Pharmacy Application Development
- Digital Medication Management Services
- Pharmacist Consultation Services
- Medication Refill Reminder Services
- Insurance Coordination Services
- Chronic Condition Support Services
- Provider Collaboration Services
Markets
- Healthcare
Business model
- Business-to-Business
- Business-to-Consumer
- Service Provider
- Healthcare
Industry codes (NAICS)
- 456110 Pharmacies and Drug Retailers 100% match
Questions about Capsule
What is Capsule worth?
Valuation $999M (range $89.2M to $1.2B), as of 24 Oct 2026. The last disclosed valuation was $1.00B (Growth Equity, Apr 2021).
Has Capsule raised money?
Capsule has 3 funding rounds on record, from Aug 2018 to Apr 2021, $550M in total. The latest disclosed valuation is $1.00B post-money (Growth Equity, Apr 2021).
Who has invested in Capsule?
Glade Brook, Thrive Capital, Durable Capital Partners, Technology Crossover Ventures, Baillie Gifford and T. Rowe Price. Lead investors include Glade Brook, Thrive Capital, Durable Capital Partners and Technology Crossover Ventures.
How many people work at Capsule?
About 838, up 1% over the last year. Headcount grew from 450 in Jan 2021 to 838 in Sep 2026.
What does Capsule do?
Capsule works in drug stores & pharmacies, with 10 recorded offerings and customers in healthcare. Its main offerings are pharmacy services platform development, prescription delivery services and medication management services.
When was Capsule founded, and where is it based?
Capsule was founded in 2015 and is based in New York, United States. It has about 838 employees, up 1% over the last year.